Product Images Desvenlafaxine Succinate

Not available.*

The text describes a figure showing the effect of other drugs on Desvenlafaxine pharmacokinetics. The figure displays the geometric mean ratio with 90% confidence intervals for the drug Ketoconazole, a CYP3A4 inhibitor. The ratios are shown for the parameters GMEX and AUC-1.43. There is a reference to a change in a chart.*

This is a table showing the effects of desvenlafaxine on the pharmacokinetics of other drugs. The drugs Desipramine, Midazolam, Tamoxifen, and Aripirpazole were tested as substrates for either CYP2D6 or CYP3A enzymes or both. The table shows the change due to interaction with Desvenlafaxine along with geometric mean ratio at 90% CI. It also includes the results for the active metabolites of Tamoxifen and Aripiprazole.*

The figure 4 shows the estimated proportion of relapses versus the number of days since randomization (Study 5) represented by a graph with the time to relapse in days from randomization in the X-axis and the relapse percentage in the Y-axis. The graph compares the relapse percentage between the Desvenlafaxine extended-release tablets 50mg and Placebo.*

This is a description of a medication called Pristiq 50mg Tablet manufactured by Lupin Limited. The package contains 30 tablets with an expiration date of MM/YY and the NDC code is 7133511501. The medication should be stored at room temperature between 20°-25°C (68°-77°F) and out of reach of children. The text also includes information about the manufacturer of the package, which is Bryant Ranck Prepack.*